4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-17-052034
Chief Executive Officer sold 4,400 shares at an average $15.02 ($66,066)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2017-09-06 | Sale | −2,200 | $15.05 | $33,110 | 439,578 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2017-09-07 | Sale | −2,200 | $14.98 | $32,956 | 437,378 | I: show line 2 in the form |
| Open-market sales · 4,400 sh · avg $15.02 · $66,066 | |||||||
Loading xslF345X03/doc4.xml…